Open-Label Phase 3 Long-Term Safety Study of Migalastat (MGM116041)
This study is currently recruiting participants.
Verified March 2013 by GlaxoSmithKline
Sponsor:
GlaxoSmithKline
Collaborator:
Amicus Therapeutics
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01458119
First received: October 20, 2011
Last updated: March 7, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2016 |
| Estimated Primary Completion Date: | July 2016 (Final data collection date for primary outcome measure) |